Integra LifeSciences Holdings Corporation Profile Avatar - Palmy Investing

Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tis…
Medical - Devices
US, Princeton [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Cash (Net)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Accounts Receivable
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Accounts Payable
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Capital Expenditure
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Purchases of Investments
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Sale/Maturity of Investment
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Property, Plant, Equipment (P&PE)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Acquisitions (Net)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Investing Activities
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Financing Activities
Used Cash (Net)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt Repayment
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Financing Activities
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Cash Balances
Begin of Period
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
End of Period
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Change
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Non-Cash Balances
Depreciation and Amortization
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Stock Based Compensation
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Highlighted metrics
Free Cash Flow (FCF)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Cash Conversion Cycle (CCC)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of IART's Analysis
CIK: 917520 CUSIP: 457985208 ISIN: US4579852082 LEI: - UEI: -
Secondary Listings
IART has no secondary listings inside our databases.